David Scheibner

This paper shows that combining N4-hydroxycytidine with CTP synthetase inhibitors strongly reduces SARS-CoV-2 replication in cell culture and animal models.

This paper shows that DHODH inhibitors enhance the antiviral effect of 4'-FlU against multiple RNA viruses, including influenza, SARS-CoV-2, and Ebola virus.

This study shows that NeuGc-adapted H7 IAVs can bind sialyl-LewisX, enabling replication in chickens and ducks despite lacking NeuGc receptors.